J Grooten
Overview
Explore the profile of J Grooten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Steemans M, Goossens V, van de Craen M, Van Herreweghe F, Vancompernolle K, de Vos K, et al.
J Exp Med
. 1998 Dec;
188(11):2193-8.
PMID: 9841933
It is well established that apoptosis is accompanied by activation of procaspases and by mitochondrial changes, such as decrease in mitochondrial transmembrane potential (DeltaPsim) and release of cytochrome c. We...
22.
Vancompernolle K, Van Herreweghe F, Pynaert G, van de Craen M, de Vos K, Totty N, et al.
FEBS Lett
. 1998 Nov;
438(3):150-8.
PMID: 9827536
Recent data show that a strong relation exists in certain cells between mitochondria and caspase activation in apoptosis. We further investigated this relation and tested whether treatment with the permeability...
23.
Rottiers P, Verfaillie T, Contreras R, Revets H, Desmedt M, Dooms H, et al.
Int J Cancer
. 1998 Oct;
78(4):503-10.
PMID: 9797141
Progression to malignancy of transformed cells involves complex genetic alterations and aberrant gene expression patterns. While aberrant gene expression is often caused by alterations in individual genes, the contribution of...
24.
Schotte P, Van Criekinge W, van de Craen M, van Loo G, Desmedt M, Grooten J, et al.
Biochem Biophys Res Commun
. 1998 Oct;
251(1):379-87.
PMID: 9790964
Members of the caspase (CASP) family of cysteine proteases can be subdivided in proapoptotic caspases and proinflammatory caspases. Whereas the apical activation pathways for the caspases that are involved in...
25.
Dooms H, Desmedt M, Vancaeneghem S, Rottiers P, Goossens V, Fiers W, et al.
J Immunol
. 1998 Sep;
161(5):2141-50.
PMID: 9725205
IL-15 shows functional redundancy with IL-2 due to its usage of the beta and gamma c subunit of the IL-2R. Yet, the requirement of IL-15 for an IL-15R alpha chain...
26.
Vercammen D, Beyaert R, Denecker G, Goossens V, van Loo G, Declercq W, et al.
J Exp Med
. 1998 Jun;
187(9):1477-85.
PMID: 9565639
Murine L929 fibrosarcoma cells treated with tumor necrosis factor (TNF) rapidly die in a necrotic way, due to excessive formation of reactive oxygen intermediates. We investigated the role of caspases...
27.
Desmedt M, Rottiers P, Dooms H, Fiers W, Grooten J
J Immunol
. 1998 May;
160(11):5300-8.
PMID: 9605128
Differentiation of naive CD4+ T cells (Th0) into Th1 or Th2 cells determines whether antigen will raise a cellular or a humoral immune response. The maturation pathway chosen by the...
28.
de Vos K, Goossens V, Boone E, Vercammen D, Vancompernolle K, Vandenabeele P, et al.
J Biol Chem
. 1998 May;
273(16):9673-80.
PMID: 9545301
The cytokine tumor necrosis factor (TNF) activates diverse signaling molecules resulting in gene expression, differentiation, and/or cell death. Here we report a novel feature induced by TNF, namely translocation of...
29.
Vanlandschoot P, Beirnaert E, Grooten J, Jou W, Fiers W
Arch Virol
. 1998 Apr;
143(2):227-39.
PMID: 9541609
We previously reported the expression of soluble A/Victoria/3/75 (H3N2) hemagglutinin in insect cells and the molecular and immunological structure of an aggregated fraction, only observed in cell supernatant when expression...
30.
Decoster E, Vanhaesebroeck B, Boone E, Plaisance S, de Vos K, Haegeman G, et al.
J Biol Chem
. 1998 Mar;
273(6):3271-7.
PMID: 9452442
Tumor necrosis factor (TNF) has a specific gene-inducing activity on many cell types and exerts a cytotoxic effect on a number of tumor cell lines. However, several tumor cell types...